Guardant Health Inc (GH)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Helmy Eltoukhy
Employees:
454
505 PENOBSCOT DR., REDWOOD CITY, CA 94063
855-698-8887

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.

Data derived from most recent annual or quarterly report
Market Cap 7.886 Billion Shares Outstanding101.656 Million Avg 30-day Volume 1.167 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.06
Price to Revenue38.8213 Debt to Equity1.3376 EBITDA-334.808 Million
Price to Book Value15.9435 Operating Margin-114.60589999999999 Enterprise Value11.91 Billion
Current Ratio19.574 EPS Growth-1.984 Quick Ratio19.1
1 Yr BETA 1.3289 52-week High/Low 181.07 / 74.48 Profit Margin-114.2119
Operating Cash Flow Growth-122.6684 Altman Z-Score5.273 Free Cash Flow to Firm -312.58 Million
View SEC Filings from GH instead.

View recent insider trading info

Funds Holding GH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

209 Thousand total shares from 16 transactions

Open Market Sells (S)

9.9 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

9.9 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MERESMAN STANLEY J

  • Director
23,796 2022-01-10 13

KAUL SAMIR

  • Director
9,002 2021-12-31 4

ELTOUKHY HELMY CO-CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
4,223,647 2021-11-19 9

TALASAZ AMIRALI CO-CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
4,123,990 2021-11-19 8

POTTER MYRTLE S

  • Director
8,896 2021-11-08 2

SAIA JOHN G. SEE REMARKS

  • Officer
12,627 2021-11-02 3

CLARK IAN T

  • Director
1,076 2021-09-01 7

JOYCE MEGHAN V.

  • Director
0 2021-08-04 2

EAGLE CRAIG CHIEF MEDICAL OFFICER

  • Officer
44,610 2021-08-03 2

FREEMAN CHRIS CHIEF COMMERCIAL OFFICER

  • Officer
58,548 2021-08-03 2

GADDE VIJAYA

  • Director
4,949 2021-06-16 1

JALLAL BAHIJA

  • Director
4,949 2021-06-16 1

BELL MICHAEL BRIAN CHIEF FINANCIAL OFFICER

  • Officer
39,701 2021-05-04 1

SVF BLUEBIRD (CAYMAN) LTD

SVF ENTERPRISE (CAYMAN) LTD

SVF ENDURANCE (CAYMAN) LTD

SB INVESTMENT ADVISERS (UK) LTD

SOFTBANK VISION FUND (AIV M1) L.P.

  • 10% Owner
No longer subject to file 2020-10-09 0

BERTOCCI DEREK A CHIEF FINANCIAL OFFICER

  • Officer
6,373 2020-09-01 0

NISHAR DIPCHAND

  • Director
2,982 2020-05-18 0

WILEY MICHAEL J CHIEF LEGAL OFFICER

  • Officer
111,171 2020-04-28 0

LANMAN RICHARD B. CHIEF MEDICAL OFFICER

  • Officer
82,015 2019-11-01 0

HILALY AAREF

  • Director
50,421 2019-08-29 0

SVF BLUEBIRD (CAYMAN) LTD

SVF ENTERPRISE (CAYMAN) LTD

SVF ENDURANCE (CAYMAN) LTD

  • 10% Owner
27,850,460 2019-07-05 0

SOFTBANK VISION FUND (AIV M1) L.P.

SB INVESTMENT ADVISERS (UK) LTD

  • 10% Owner
53,666,890 2019-03-12 0

TLS BETA PTE. LTD.

TEMASEK LIFE SCIENCES PRIVATE LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
No longer subject to file 2018-10-09 0

KHOSLA VENTURES IV, L.P.

KHOSLA VENTURES IV (CF), L.P.

KHOSLA VENTURES ASSOCIATES IV, LLC

VK SERVICES, LLC

KHOSLA VINOD

  • 10% Owner
  • FORMER 10% OWNER
No longer subject to file 2018-10-09 0

ORBIMED ADVISORS LLC

  • 10% Owner
No longer subject to file 2018-10-09 0

SOFTBANK GROUP CAPITAL LTD

SOFTBANK GROUP CORP

  • 10% Owner
No longer subject to file 2018-10-09 0

LIGHTSPEED ULTIMATE GENERAL PARTNER X, LTD.

LIGHTSPEED AFFILIATES X, L.P.

LIGHTSPEED VENTURE PARTNERS X, L.P.

LIGHTSPEED GENERAL PARTNER X, L.P.

EGGERS BARRY

LIEW JEREMY

MHATRE RAVI

NIEH PETER

SCHAEPE CHRISTOPHER J

  • 10% Owner
No longer subject to file 2018-10-09 0

LIGHTSPEED ULTIMATE GENERAL PARTNER SELECT, LTD.

LIGHTSPEED VENTURE PARTNERS SELECT, L.P.

LIGHTSPEED GENERAL PARTNER SELECT, L.P.

EGGERS BARRY

LIEW JEREMY

MHATRE RAVI

NIEH PETER

SCHAEPE CHRISTOPHER J

  • 10% Owner
No longer subject to file 2018-10-09 0

SC US (TTGP), LTD.

SC U.S. VENTURE 2010 MANAGEMENT, L.P.

SEQUOIA CAPITAL U.S. VENTURE 2010-SEED FUND, L.P.

SEQUOIA CAPITAL SCOUT FUND II, L.L.C.

SANDSCAPE, LLC

SC U.S. VENTURE XIV MANAGEMENT, L.P.

SEQUOIA CAPITAL U.S. VENTURE FUND XIV, L.P.

SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XIV, L.P.

SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XIV (Q), L.P.

SEQUOIA CAPITAL USV XIV HOLDCO, LTD.

  • 10% Owner
No longer subject to file 2018-10-09 0

DAS-YOUNG LEENA CHIEF LUNAR OFFICER AND GM

  • Officer
0 2018-10-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MERESMAN STANLEY J - Director

2022-01-12 16:16:52 -0500 2022-01-10 M 4,934 $5.94 a 8,993 direct -1.5482 0.0 1 -1.5482 2

MERESMAN STANLEY J - Director

2022-01-12 16:16:52 -0500 2022-01-10 M 4,934 d 19,737 direct

MERESMAN STANLEY J - Director

2022-01-12 16:16:52 -0500 2022-01-10 S 4,934 $86.08 d 4,059 direct -1.5482 0.0 1 -1.5482 2

MERESMAN STANLEY J - Director

2021-12-14 17:46:23 -0500 2021-12-10 M 4,934 $5.94 a 8,993 direct 1.2534 3.0557 6.7951 3 0.0 1

MERESMAN STANLEY J - Director

2021-12-14 17:46:23 -0500 2021-12-10 M 4,934 d 24,671 direct

MERESMAN STANLEY J - Director

2021-12-14 17:46:23 -0500 2021-12-10 S 4,934 $95.59 d 4,059 direct 1.2534 3.0557 6.7951 3 0.0 1

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-23 P 23,467 $93.05 a 1,828,845 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-23 P 14,900 $96.83 a 1,853,745 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-23 P 5,000 $94.00 a 1,936,186 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-23 P 100 $98.00 a 1,956,186 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-23 P 6,033 $92.42 a 1,805,378 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-23 P 5,000 $95.50 a 1,838,845 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-23 P 26,394 $93.04 a 1,931,186 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-23 P 14,900 $96.83 a 1,956,086 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-23 P 5,000 $94.00 a 1,833,845 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-23 P 100 $98.00 a 1,853,845 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-23 P 3,106 $92.23 a 1,904,792 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-23 P 5,000 $95.50 a 1,941,186 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-19 P 37,721 $97.82 a 1,787,066 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-19 P 12,409 $98.75 a 1,901,686 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

ELTOUKHY HELMY - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:37 -0500 2021-11-19 P 37,591 $97.90 a 1,889,277 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

TALASAZ AMIRALI - Director - Officer CO-CHIEF EXECUTIVE OFFICER

2021-11-23 19:07:02 -0500 2021-11-19 P 12,279 $98.78 a 1,799,345 direct -0.3077 -10.5082 -18.1072 0.0 1 -18.1072 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GUARDANT HEALTH INC GH 2022-01-17 20:45:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 20:15:04 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 19:45:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 19:15:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 18:45:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 18:15:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 17:45:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 17:15:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 16:45:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 16:15:04 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 15:45:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 15:15:03 UTC -0.18 0.25 750000
GUARDANT HEALTH INC GH 2022-01-17 14:45:03 UTC -0.2062 0.2762 750000
GUARDANT HEALTH INC GH 2022-01-17 14:15:03 UTC -0.2062 0.2762 750000
GUARDANT HEALTH INC GH 2022-01-17 13:45:03 UTC -0.2062 0.2762 750000
GUARDANT HEALTH INC GH 2022-01-17 13:15:03 UTC -0.2062 0.2762 750000
GUARDANT HEALTH INC GH 2022-01-17 12:45:03 UTC -0.2062 0.2762 750000
GUARDANT HEALTH INC GH 2022-01-14 22:15:03 UTC -0.2062 0.2762 750000
GUARDANT HEALTH INC GH 2022-01-14 21:45:03 UTC -0.2062 0.2762 750000
GUARDANT HEALTH INC GH 2022-01-14 21:15:03 UTC -0.2062 0.2762 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund GH -38.0 shares, $-4247.64 2020-09-30 N-PORT
Advisors Series Trust- Pzena Long/Short Value Fund GH -1509.0 shares, $-136398.51 2020-05-31 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund GH -1232.0 shares, $-117656.0 2020-08-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund GH -6.0 shares, $-670.68 2020-09-30 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund GH -4886.0 shares, $-745847.9 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund GH -700.0 shares, $-86933.0 2021-06-30 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund GH -2167.0 shares, $-237936.6 2021-07-31 N-PORT
Leuthold Funds Inc- Leuthold Core Investment Fund GH -2676.0 shares, $-334526.76 2021-09-30 N-PORT
Leuthold Funds Inc- Leuthold Global Fund GH -9.0 shares, $-1125.09 2021-09-30 N-PORT
Leuthold Funds Inc- Grizzly Short Fund GH -2264.0 shares, $-283022.64 2021-09-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund GH -2829.0 shares, $-353653.29 2021-09-30 N-PORT
AQR Funds- AQR Multi-Asset Fund GH -796.0 shares, $-99507.96 2021-09-30 N-PORT
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund GH -10742.0 shares, $-1342857.42 2021-09-30 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund GH -261.0 shares, $-32627.61 2021-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund GH -718.0 shares, $-89757.18 2021-09-30 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity Fund GH -593.0 shares, $-62336.16 2021-11-30 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND GH -962.0 shares, $-112351.98 2021-10-31 N-PORT

Elevate your investments